Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
- Conditions
- Lymph Node MetastasisGastric Cancer Stage
- Interventions
- Diagnostic Test: coagulation-related factors
- Registration Number
- NCT05592925
- Lead Sponsor
- Shandong Provincial Hospital
- Brief Summary
We initially selected a total of 1128 patients with primary gastric cancer who presented at Shandong Provincial Hospital between January 2018 and October 2022, and retrospectively collected their clinical and pathological data. And retrospectively analyzed preoperative baseline characteristics, preoperative laboratory tests, and postoperative pathological results for these patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 516
- patients with primary gastric malignant tumors,
- patients who underwent radical resection of gastric cancer,
- patients with a postoperative pathology of adenocarcinoma or signet ring cell carcinoma according to the WTO pathological classification,
- patients who have distant metastases, such as liver or lung metastases, were found on preoperative ultrasound and computed tomography (CT) examinations,
- patients who have received preoperative neoadjuvant chemotherapy,
- patients who take anticoagulant drugs (such as aspirin) prior to surgery,
- patients who had any previous coagulation disorder.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description N0 coagulation-related factors gastric cancer patients with no lymph node metastasis N+ coagulation-related factors gastric cancer patients with lymph node metastasis, including patients with N1, N2 and N3 stage cancer
- Primary Outcome Measures
Name Time Method Preoperative coagulation-related factors (fibrinogen levels) of patients Three years Fibrinogen levels (g/L). Measure the data of preoperative fibrinogen levels in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Preoperative coagulation-related factors (MA values) of patients Three years MA values(mm). Measure the data of preoperative MA values in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Preoperative coagulation-related factors (platelet counts) of patients Three years Platelet counts(x10\^9/L). Measure the data of preoperative platelet counts in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Preoperative coagulation-related factors (D-dimer) of patients Three years D-dimer (mg/L). Measure the data of preoperative D-dimer in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Postoperative pathological results of tumor N stage. Three years. Recording the postoperative pathological tumor N stage in 516 patients with gastric cancer.
Postoperative pathological results of tumor T stage. Three years Recording the postoperative pathological tumor T stage in 516 patients with gastric cancer.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shandong Provincial Hospital
🇨🇳Jinan, Shandong, China